Second-trimester serum fluorescence polarization in patients who subsequently develop pregnancy-induced hypertension

被引:1
|
作者
Barkai, G [1 ]
Ries, L [1 ]
Lusky, A [1 ]
Korach, J [1 ]
Mashiach, S [1 ]
Schiff, E [1 ]
机构
[1] CHAIM SHEBA MED CTR, DEPT OBSTET & GYNECOL, INST HUMAN GENET, IL-52621 TEL HASHOMER, ISRAEL
关键词
pregnancy-induced hypertension; fluorescence polarization; cholesterol; triglycerides;
D O I
10.1055/s-2007-994350
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
To determine whether the midtrimester serum lipid profile, as expressed by fluorescence polarization (FP) values, is decreased in patients who subsequently develop pregnancy-induced hypertension (PIH). Stored serum samples of normotensive patients who had undergone midtrimester biochemical screening for Down's syndrome were used in this case-control study. Forty patients who subsequently developed PIH comprised the study group, and were divided into subgroups with proteinuric PIH (P-PIH, n = 18) and those with nonproteinuric PIH (NP-PIH, n = 22). Sixty randomly selected patients who remained normotensive throughout pregnancy comprised the control. Serum total cholesterol (CL) and triglycerides (TC) were determined using enzymatic colorimetric kits. FP values were determined by optical microviscosimeter. Both study subgroups had significantly lower FP values and higher TG concentrations than the control group. Total CL concentrations were slightly higher in the P-PIH subgroup. There were no differences in mean. Total CL or TG concentrations or mean FP values were found between those patients who developed mild and severe PIH. Using FP value cutoff points of 0.250, 0.245, and 0.240 sensitivity was 95%, 90%, and 78%, respectively, in detecting patients who subsequently developed PIH. Midtrimester serum FP values may have some predictive value for the development of P- and NP-PIH.
引用
收藏
页码:323 / 327
页数:5
相关论文
共 50 条
  • [1] Second-trimester plasma homocysteine levels and pregnancy-induced hypertension, preeclampsia, and intrauterine growth restriction
    Hogg, BB
    Tamura, T
    Johnston, KE
    DuBard, MB
    Goldenberg, RL
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (04) : 805 - 809
  • [3] Serum βhCG and lipid profile in early second trimester as predictors of pregnancy-induced hypertension
    Yadav K.
    Aggarwal S.
    Verma K.
    The Journal of Obstetrics and Gynecology of India, 2014, 64 (3) : 169 - 174
  • [4] First- and second-trimester uterine artery pulsatility index as a combination factor in predictive diagnosis of pregnancy-induced hypertension
    Dash, Sonali S.
    Jena, Pramila
    Khuntia, Swetaparna
    Pathak, Mona
    Rath, Sudhanshu K.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2021, 154 (03) : 431 - 435
  • [5] Phenotypes of Pregnant Women Who Subsequently Develop Hypertension in Pregnancy
    McLaughlin, Kelsey
    Zhang, Jianhong
    Lye, Stephen J.
    Parker, John D.
    Kingdom, John C.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (14):
  • [6] Association between ELABELA Serum Concentrations in First Trimester and Pregnancy-Induced Hypertension
    Ma, Shujuan
    Guo, Chuhao
    Zhang, Jiayue
    Long, Sisi
    Tan, Hongzhuan
    You, Yiping
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [7] First Trimester Serum Copper or Zinc Levels, and Risk of Pregnancy-Induced Hypertension
    Lewandowska, Malgorzata
    Sajdak, Stefan
    Marciniak, Wojciech
    Lubinski, Jan
    NUTRIENTS, 2019, 11 (10)
  • [8] Early second-trimester plasma levels of NT-proBNP in women who subsequently develop early-onset preeclampsia
    Junus, Katja
    Wikstrom, Anna-Karin
    Larsson, Anders
    Olovsson, Matts
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2017, 30 (18): : 2163 - 2165
  • [9] LYMPHOCYTE-REACTIVITY IN PATIENTS DESTINED TO DEVELOP PREGNANCY-INDUCED HYPERTENSION
    THURNAU, GR
    ROTE, NS
    SCOTT, JR
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1983, 3 (04): : 198 - 198
  • [10] Pregnancy outcomes after removal of osmotic dilators in patients who presented for second-trimester abortion
    Mark, Katrina
    Merchant, Rashida M.
    Hu, Kevin
    CONTRACEPTION, 2019, 99 (05) : 285 - 287